
Shares of anti-opioid treatment maker Indivior INDV.L rise as much as 6.3% to 738.5p
Co reports Q1 total net revenue of $266 million, which was above consensus of $243 million, according to Jefferies analysts
Co also reiterated its FY2025 guidance
Adds it expects its key product, SUBLOCADE, to grow again in second-half of the year
Up to Wednesday's close, stock had fallen about 31% so far this year